Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C38724
http://purl.obolibrary.org/obo/NCIT_C38724
|
|---|---|
| Preferred Name | Recombinant MAGE-3.1 Antigen |
| Definitions |
A recombinant tumor-specific melanoma antigen. Vaccination with recombinant MAGE-3.1 antigen may induce a host immune response against MAGE-expressing cells, resulting in antitumoral T cell-mediated cytotoxicity. MAGE-expressing cells are found in melanoma, non-small-cell lung carcinoma (NSCLC), head and neck squamous cell carcinoma, transitional cell carcinoma of the bladder, and esophageal carcinoma. (NCI04)
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A recombinant tumor-specific melanoma antigen. Vaccination with recombinant MAGE-3.1 antigen may induce a host immune response against MAGE-expressing cells, resulting in antitumoral T cell-mediated cytotoxicity. MAGE-expressing cells are found in melanoma, non-small-cell lung carcinoma (NSCLC), head and neck squamous cell carcinoma, transitional cell carcinoma of the bladder, and esophageal carcinoma. (NCI04) |
|---|---|
| prefLabel | Recombinant MAGE-3.1 Antigen
|
| label | Recombinant MAGE-3.1 Antigen
|
| PDQ_Closed_Trial_Search_ID | 42271
|
| code | C38724
|
| Has_Target | |
| prefixIRI | NCIT:C38724
|
| in_subset |
See more
See less
|
| Display_Name | Recombinant MAGE-3.1 Antigen
|
| Preferred_Name | Recombinant MAGE-3.1 Antigen
|
| Contributing_Source | CTRP
|
| Maps_To | Recombinant MAGE-3.1 Antigen
|
| NCI_Drug_Dictionary_ID | 42271
|
| Legacy Concept Name | Recombinant_MAGE-3-1_Antigen
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 42271
|
| Semantic_Type |
Amino Acid, Peptide, or Protein
Immunologic Factor
|
| UMLS_CUI | C1510427
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |